Ellen Geisel retired in March of 2017 as President of IMH, where she led the launch of the company’s medical foods pipeline, including the flagship products, IBgard and FDgard. She remains active with the company as a senior advisor.

Ellen has over 35 years of experience in commercial leadership positions in Big Pharma (Smith-Kline, Wyeth, Pharmacia, Schering-Plough and Merck). Ellen joined IMH from Merck, where she was a senior executive with global responsibility for 800 employees. She was also a member of Merck’s Executive Management Team, responsible for managing overall company performance.

Ellen has had direct involvement with leading products such as Premarin, Celebrex, Detrol, Nasonex and NuvaRing.

She received her MBA from LaSalle Graduate School of Business in Philadelphia, PA.